Reboxetine for treatment obsessive compulsive disorders and panic disorder
US6391876B1 · kind B1 · utility
0Cited by
3References
5Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 19, 2000 |
| Grant date | May 21, 2002 |
| Priority date | — |
| Expiry date | Oct 19, 2020 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P25/22
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This invention relates to the use of reboxetine in the treatment of Obsessive Compulsive Disorders and Panic Disorders.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.